Terry Kim, MD, to serve as chief medical officer, head of global medical safety at Alcon
Click Here to Manage Email Alerts
Key takeaways:
- Terry Kim, MD, will integrate scientific and clinical priorities in the surgical and vision care franchises.
- Stephen S. Lane, MD, is retiring after 7 years at Alcon.
Terry Kim, MD, is joining Alcon as chief medical officer and head of global medical safety, according to a press release.
In this role, Kim will help guide the integration of scientific and clinical priorities in Alcon’s surgical and vision care franchises to meet the needs of eye care practitioners and patients globally.
Kim, a professor of ophthalmology at Duke University Eye Center, will also “support the development of surgical and vision care clinical evidence and represent Alcon to academic, scientific and industry communities as well as government agencies.”
Kim succeeds Stephen S. Lane, MD, who served at Alcon for 7 years and is retiring after working in ophthalmology for 39 years.
“Dr. Kim is an exceptional addition to our team, and we look forward to leveraging his world-class cataract-refractive experience to build upon the efforts spearheaded by Dr. Lane,” Franck Leveiller, chief scientific officer, global head R&D, Alcon, said in the release. “Bringing Dr. Kim to Alcon is a testament to our ongoing commitment in leveraging experts to inform our innovations aimed at meeting the evolving needs of eye care professionals and their patients. Dr. Kim’s expertise — in partnership with leading industry professionals — will help us continue to advance our mission to deliver bold innovations.”
Read more about
Click Here to Manage Email Alerts